Overview of Inflammation Pathways

Inflammation is a multifaceted biological response that involves various signaling pathways, each playing a crucial role in the regulation of immune responses to injury or infection. This literature review synthesizes current knowledge on the major inflammatory pathways, including the Nuclear Factor kappa B (NF-κB) pathway, the Mitogen-Activated Protein Kinase (MAPK) pathway, the Type I Interferon (IFN) signaling pathway, the cGAS-cGAMP-STING pathway, and the TLR4 signaling pathway, among others. Additionally, the review will explore the interplay between these pathways and their implications in various inflammatory diseases.

The NF-κB pathway is a central regulator of inflammation, primarily responsible for the transcription of pro-inflammatory cytokines. Activation of this pathway occurs through various receptors, including Toll-like receptors (TLRs) and tumor necrosis factor (TNF) receptors, leading to the phosphorylation and degradation of IκB proteins. This degradation allows NF-κB dimers, such as p65, to translocate to the nucleus and initiate the transcription of genes involved in inflammation (Sun et al., 2020). The NF-κB pathway is implicated in numerous chronic inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease, highlighting its significance in both acute and chronic inflammatory responses (Sun et al., 2020).

The MAPK pathway encompasses three major signaling cascades: Extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK. Each of these pathways is activated by various stimuli, including cytokines and stress signals, and they play distinct roles in mediating inflammatory responses. For instance, p38 MAPK is particularly important in regulating the production of pro-inflammatory cytokines such as TNF-α and IL-6, and it is often activated in response to stress and inflammatory signals (Victorino & Alper, 2012). The interplay between MAPK pathways and NF-κB signaling is crucial for the amplification of the inflammatory response, as both pathways can synergistically enhance the expression of inflammatory mediators (Victorino & Alper, 2012).

The Type I Interferon signaling pathway is crucial in mediating antiviral responses and is activated by the recognition of viral RNA or DNA. This pathway enhances the production of pro-inflammatory cytokines and recruits immune cells to sites of infection. Pezzanite et al. highlight that Type I IFNs can activate various inflammatory pathways, thereby amplifying the immune response (Yang et al., 2014). Furthermore, the activation of this pathway is essential in conditions such as ischemia/reperfusion injury, where it mediates inflammation and tissue damage (Beamer et al., 2012).

The cGAS-cGAMP-STING pathway is another important mediator of inflammation, particularly in response to cytosolic DNA. This pathway is activated when DNA is detected in the cytoplasm, leading to the production of cyclic GMP-AMP (cGAMP) and subsequent activation of the STING protein. This activation results in the production of Type I IFNs and other inflammatory cytokines, as demonstrated by Bi et al., who showed that this pathway is involved in the inflammatory response during periodontitis (Perkins et al., 2019). Additionally, DsbA-L has been shown to prevent obesity-induced inflammation by inhibiting the cGAS-cGAMP-STING pathway, suggesting its role in metabolic inflammation (Sadik & Luster, 2011).

The TLR4 signaling pathway is a critical component of the innate immune response, particularly in recognizing pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharides (LPS) from Gram-negative bacteria. Activation of TLR4 leads to the recruitment of various signaling molecules, including IRAK4 and NF-κB, which promote the expression of pro-inflammatory cytokines (Serhan & Levy, 2018). This pathway is implicated in various inflammatory conditions, including obesity-related inflammation and sepsis (Serhan & Levy, 2018). For instance, Rogero and Calder discuss how TLR4 activation contributes to the chronic low-grade inflammation observed in obesity (Muralidharan & Mandrekar, 2013).

Moreover, the interplay between these pathways can significantly influence the inflammatory response. For example, Wu et al. demonstrated that angiotensin II can induce macrophage polarization through the connexin 43/NF-κB pathway, linking TLR4 signaling to NF-κB activation and subsequent inflammatory cytokine production (Cara et al., 2019). This cross-talk among pathways highlights the complexity of the inflammatory response and the potential for targeting multiple pathways in therapeutic strategies.

In addition to these pathways, the RAGE (Receptor for Advanced Glycation End-products) pathway is also significant in inflammation. RAGE interacts with various ligands, including advanced glycation end-products (AGEs), and activates NF-κB, leading to sustained inflammatory responses (Dong, 2020). This pathway has been implicated in several chronic inflammatory conditions, including diabetes and neurodegenerative diseases, emphasizing its role in perpetuating inflammation (Dong, 2020).

The JAK-STAT signaling pathway is another critical mediator of inflammation, particularly in the context of cytokine signaling. This pathway is activated by various inflammatory cytokines, leading to the phosphorylation and activation of STAT proteins, which translocate to the nucleus to regulate gene expression.

The JAK-STAT pathway has been recognized as a pivotal component in the inflammatory process and pain amplification in conditions such as arthritis (Machairiotis et al., 2021). Furthermore, the cholinergic anti-inflammatory pathway (CAIP) represents a neuro-immune communication mechanism that modulates inflammation through vagal nerve stimulation. This pathway has been shown to inhibit excessive immune cell activation and reduce pro-inflammatory cytokine production, highlighting the potential for neuro-modulatory strategies in managing inflammatory diseases (Abramiuk et al., 2022).

In summary, the NF-κB, MAPK, Type I IFN, cGAS-cGAMP-STING, TLR4, RAGE, JAK-STAT, and cholinergic anti-inflammatory pathways are integral components of the inflammatory response. Their activation leads to the production of pro-inflammatory cytokines and the recruitment of immune cells, underscoring their importance in both acute and chronic inflammatory conditions. Understanding these pathways provides insights into the mechanisms underlying various inflammatory diseases and highlights potential therapeutic targets for intervention.